Diana Costa Alves
About Diana Costa Alves
Diana Costa Alves is a Market Access Manager specializing in Health Economics and Outcomes Research at Bristol-Myers Squibb, with extensive experience in regulatory sciences and quality assurance.
Title and Role
Diana Costa Alves is currently serving as the Market Access Manager in Health Economics and Outcomes Research at Bristol-Myers Squibb. In this capacity, she is involved in managing reimbursement request processes, therapeutic added value dossiers, and Early Access Programs. Diana also leads real-world data projects and annual price revisions, collaborating with key external stakeholders like oncologists and oncology pharmacists to develop supportive studies or projects.
Employment at Bristol-Myers Squibb
Diana Costa Alves has held multiple roles at Bristol-Myers Squibb. From 2016 to 2017, she worked in an internal assignment in the Market Access department. Prior to that, from 2015 to 2017, she served as the Regulatory Sciences Manager and Quality Assurance, Interim Technical Director. Additionally, in 2015, she was a Regulatory Sciences Associate for 11 months. Diana has developed extensive expertise in market access, regulatory sciences, and quality assurance during her tenure.
Previous Roles and Experience
Before joining Bristol-Myers Squibb, Diana Costa Alves worked at various organizations. From 2014 to 2015, she was the Regulatory Sciences Manager and Pharmacovigilance at Boehringer Ingelheim, Lda. She also served as Regulatory Sciences and Quality Assurance Officer and Pharmacovigilance at Pharmaffairs Pharmaceutical Consulting in 2014. Prior to these roles, she was a Regulatory Affairs Officer and Quality Assurance at Laboratórios Azevedos from 2013 to 2014, and a Quality Assurance Trainee at Baxter Médico-Farmacêutica from 2012 to 2013.
Education and Expertise
Diana Costa Alves holds multiple academic qualifications. She earned a Course of Outcomes Research in Health from the National School of Public Health (Lisbon) in 2020. From 2017 to 2018, she pursued a Post-Graduate in Economic Evaluation of Medicines at the Higher Institute of Economics and Management of Lisbon (ISEG – Executive Education). In 2012, she completed a Post-Graduate in Marketing for Pharmacists at the Faculty of Pharmacy, University of Lisbon. Her foundational education includes a Pharmacy Degree in Pharmaceutical Sciences from the same institution, completed in 2012.
Involvement in Health Economics and Outcomes Research (HEOR)
Diana Costa Alves has a specialized focus in Health Economics and Outcomes Research (HEOR). Her work encompasses managing reimbursement request processes and therapeutic added value dossiers. She is also involved in Early Access Programs, leading real-world data projects, and conducting annual price revisions. Her collaborative efforts with oncologists and oncology pharmacists help in developing supportive studies and projects in the fields of oncology, cardiovascular, and hematology.